🇺🇸 FDA
Pipeline program

QFR

FAVOR III China - 2508

Unknown other active

Quick answer

QFR for Coronary Artery Disease is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Coronary Artery Disease
Phase
Unknown
Modality
other
Status
active

Clinical trials